Induction chemotherapy and surgery of colorectal liver metastases;Chimiothérapie d'induction et chirurgie des métastases hépatiques du cancer colorectal

Bulletin du Cancer

Volumn 93, Issue SPEC. ISS., 2006, Pages

  Adam, René ^a   Vibert, Éric ^a   Pitombo, Marcos ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

Chemotherapy; Colorectal cancer; Liver metastasis; Onco surgical strategy; Surgery

Indexed keywords

CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CHEMOTHERAPY; COLORECTAL TUMOR; HUMAN; LIVER METASTASIS; POSTOPERATIVE PERIOD; REVIEW; SHORT COURSE THERAPY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CLINICAL TRIAL; LIVER RESECTION; LIVER TUMOR; METASTASIS; PATHOLOGY;

ANTINEOPLASTIC AGENT; OXALIPLATIN; PLATINUM COMPLEX;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS;

EID: 33644858111     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Mann CD, Metcalfe MS, Leopardi LN, Maddern GJ. The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg 2004; 139: 1168-72.
2. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-25; (discussion 825-7).
3. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-66.
4. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240: 644-57.
5. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004; 240: 438-47.
6. De Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-47.
7. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet 2000; 355: 1041-7.
8. Topham C, Adam R. Oncosurgery: a new reality in metastatic colorectal carcinoma. Semin Oncol 2002; 29: 3-10.
9. Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy: an intergroup study. J Clin Oncol 2002; 20: 1499-505.
10. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341: 2039-48.
11. Portier G, Rougier P, Milan C. Adjuvant systemic chemotherapy using 5-fluorouracil and folinic acid after resection of liver metastases from colorectal origin. Results of an intergroup phase III study (trial FFCD-ACHBTH-AURC 9002). Proc Am Soc Clin Oncol 2002.
12. Langer B, Bleiberg H, Labianca R. Fluorouracil (FU) plus 1-leucovorin (1-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer: results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. Proc Am Soc Clin Oncol 2002.
13. Nordlinger B, Ducreux M, Wasan H, Pozzo C. The role of irinotecan in the treatment of colorectal cancer metastases: surgeons and oncologist in partnership. Eur J Cancer 2004; 2: 27-33.
14. Nordlinger B, Sorbye H, Debois M. Feasibility and risks of pre-operative chemotherapy with folfox4 and surgery for resectable colorectal cancer liver metastases, interim results of the EORTC intergroup randomized phase III study 40983. Proc Am Soc Clin Oncol 2005.
15. Tanaka K, Adam R, Shimada H, Azoulay D, Levi F, Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003; 90: 963-9.
16. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-18; (discussion 318-21).
17. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996; 77: 1254-62.
18. Malafosse R, Penna C, Sa Cunha A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12: 887-94.
19. Adam R, Lucidi V, Bismuth H. Hepatic colorectal metastases: methods of improving resectability. Surg Clin North Am 2004; 84: 659-71.
20. de Baere T. Radiofrequency in cancerology. Bull Cancer 2005; 92: 65-74.
21. Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg 1999; 86: 158-69.
22. Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet 1997; 350: 681-6.
23. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-42.
24. Taberno JM, Van Cutsem E, Sastre J. An international phase II study of cetuximab in combination with FOLFOX4 in the first-line treatment of patients with metastastic colorectal (CRC) expressing epidermal growth factor receptor (EGFR): Preliminary results. Proc Am Soc Clin Oncol 2004.
25. Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999; 10: 663-9.
26. Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, et al. Folfiri followed by Folfox6 or the reverse sequence in advanced colorectal cancer: a randomized Gercor study. J Clin Oncol 2004; 22: 229-37.
27. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004; 22: 23-30.
28. Goldberg RM, Gill S. Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancer. Cancer Chemother Pharmacol 2004; 54(Suppl 1): S57-S64.
29. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224: 509-20.
30. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001; 8: 347-53.
31. Rivoire M, De Cian F, Meeus P, Negrier S, Sebban H, Kaemmerlen P. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer 2002; 95: 2283-92.
32. Pozzo C, Basso M, Cassano A, Quirino M, Schinzari G, Trigila N, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 2004; 15: 933-9.
33. Elias D, Youssef O, Sideris L, Dromain C, Baton O, Boige V, et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol 2004; 86: 4-9.
34. Adam R, Bismuth H, Castaing D, Waechter F, Navarro F, Abascal A, et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg 1997; 225: 51-60.
35. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004; 240: 1052-61.
36. Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003; 7: 109-15.
37. Levi F, Misset JL, Brienza S, Adam R, Metzger G, Itzakhi M, et al. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer. Cancer 1992; 69: 893-900.
38. Wein A, Riedel C, Bruckl W, Merkel S, Ott R, Hanke B, et al. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology 2003; 64: 131-8.
39. Alberts SR, Donohue JH, Mahoney MR, Horvath WL, Sternfeld SR, Dakhil R, et al. Liver resection after 5-fluorouracil, leucovorin and oxaliplarin for patients with metastatic colorectal cancer limited to the liver: a North Central Cancer Treatment Group phase II study. Proc Am Soc Clin Oncol 2003.
40. Abad A, Anton A, Massuti F, Rivera E, Marcuello M, Navarro J, et al. Resectability of liver metastases in patients with advanced colorectal cancer after treatment with the combination of oxaliplatin, irinotecan and 5FU. Final results of a phase II study. Proc Am Soc Clin Oncol 2005.
41. De Baere T. La radiofréquence en cancérologie. Bull Cancer 2005; 92: 65-74.
42. Abdalla EK, Vauthey JN, Ellis V, Pollock R, Broglio KR, Hess K, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-25.